A fibril-selective single-domain antibody targets pathogenic amyloid-β assemblies and protects human neurons iScience (2026), (Vol. 19, 11). DOI: 10.1016/j.isci.2026.117946 Greenlee, M., Amniousel, S., Rivera, I. et al. (2026)
iScience (2026), (Vol. 19, 11). DOI: 10.1016/j.isci.2026.117946